Cytochrome c oxidase is decreased in Alzheimer's disease platelets

Neurobiology of Aging

Volumn 25, Issue 1, 2004, Pages 105-110

  Cardoso, Sandra Morais ^a   Proença, M Teresa ^a,b   Santos, Sancha ^a   Santana, Isabel ^b   Oliveira, Catarina R ^a,b,c  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Alzheimer's disease; Cytochrome oxidase; Platelets

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHA TOCOPHEROL; CHOLESTEROL; CYTOCHROME C OXIDASE; REACTIVE OXYGEN METABOLITE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME SUBUNIT; HUMAN; HUMAN CELL; MEMBRANE FLUIDITY; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THROMBOCYTE;

EID: 0348111546     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(03)00033-2     Document Type: Article

References (37)

1. Anderson S., Bankier A.T., Barrell B.G., de Bruijn M.H., Coulson A.R., Drouin J.et al. Sequence and organization of the human mitochondrial genome. Nature. 290:1981;457-465.
2. Bass D.A., Parce J.W., Dechatelet L.R., Szejda P., Seeds M.C., Thomas M. Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J. Immunol. 130:1983;1910-1917.
3. Beal M.F. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann. Neurol. 31:1992;119-130.
4. Bennett M.C., Diamond D.M., Stryker S.L., Parks J.K., Parker W.D. Jr. Cytochrome oxidase inhibition: a novel animal model of Alzheimer's disease. J. Geriatr. Psychiatry Neurol. 5(2):1992;93-101.
5. Benzi G., Curti D., Pastoris O., Marzatico F., Villa R.F., Dagani F. Sequential damage in mitochondria complexes by peroxidative stress. Neurochem. Res. 16:1991;1295-1302.
6. 2 and modulation by glutathione in human neuroblastoma and Alzheimer's disease cybrid cells. Brain Res. Mol. Brain Res. 71(1):1999;69-77.
7. Boveris A., Chance B. The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem. J. 134:1973;707-716.
8. Cassarino D.S., Swerdlow R.H., Parks J.K., Parker W.D. Jr., Bennett J.P. Jr. Cyclosporin A increases resting mitochondrial membrane potential in SY5Y cells and reverses the depressed mitochondrial membrane potential of Alzheimer's disease cybrids. Biochem. Biophys. Res. Commun. 248(1):1998;168-173.
9. Coore H.G., Denton R.M., Martin B.R., Randle P.J. Regulation of adipose tissue pyruvate dehydrogenase by insulin and others hormones. Biochem. J. 125:1971;115-127.
10. Goldstein S., Czapski G., Cohen H., Meyerstein D. Free radicals induced peptide damage in the presence of transition metal ions: a plausible pathway for biological deleterious processes. Free Radic. Biol. Med. 17:1994;11-18.
11. Gorg A., Postel W., Friedrich C., Kuick R., Strahler J.R., Hanash S.M. Temperature-dependent spot positional variability in two-dimensional polypeptide patterns. Electrophoresis. 12:1991;653-658.
12. Halliwell B. Reactive oxygen species and the central nervous system. J. Neurochem. 59:1992;1609-1623.
13. Katzman R. Alzheimer's disease. N. Engl. J. Med. 314:1986;964-973.
14. Khan S.M., Cassarino D.S., Abramova N.N., Keeney P.M., Borland M.K., Trimmer P.A.et al. Alzheimer's disease cybrids replicate beta-amyloid abnormalities through cell death pathways. Ann. Neurol. 48(2):2000;148-155.
15. King T.E. Preparations of succinate-cytochrome c reductase and the cytochrome b-c1 particle and reconstitution of succinate-cytochrome c reductase. Methods Enzymol. 10:1967;216-225.
16. Kish S.J., Bergeron C., Rajput A., Dozic S., Mastrogiacomo F., Chang L.J.et al. Brain cytochrome oxidase in Alzheimer's disease. J. Neurochem. 59:1992;776-779.
17. Kish S.J., Mastrogiacomo F., Guttman M., Furukawa Y., Taanman J.W., Dozic S.et al. Decreased brain protein levels of cytochrome oxidase subunits in Alzheimer's disease and in hereditary spinocerebellar ataxia disorders: a nonspecific change? J. Neurochem. 72:1999;700-707.
18. Krige D., Carroll M.T., Cooper J.M., Marsden C.D., Schapira A.H. Platelet mitochondria function in Parkinson's disease. The Royal Kings and Queens Parkinson Disease Research Group. Ann. Neurol. 32:1992;782-788.
19. Mason R.P., Walter M.F., Mason P.E. Effect of oxidative stress on membrane structure: small-angle X-ray diffraction analysis. Free Radic. Biol. Med. 23:1997;419-425.
20. Parker W.D. Jr., Filley C.M., Parks J.K. Cytochrome oxidase deficiency in Alzheimer's disease. Neurology. 40:1990;1302-1303.
21. Parker W.D. Jr., Mahr N.J., Filley C.M., Parks J.K., Hughes D., Young D.A.et al. Reduced platelet cytochrome c oxidase activity in Alzheimer's disease. Neurology. 44:1994;1086-1090.
22. Parker W.D. Jr., Parks J., Filley C.M., Kleinschmidt-DeMasters B.K. Electron transport chain defects in Alzheimer's disease brain. Neurology. 44(6):1994;1090-1096.
23. Ragan CI, Wilson MT, Darley-Usmar VM, Lowe PN. Subfractionation of mitochondria, and isolation of the proteins of oxidative phosphorylation. In: Mitochondria, a practical approach. London: IRL Press; 1987. p. 79-112.
24. Reinheckel T., Wiswedel I., Noack H., Augustin W. Electrophoretic evidence for the impairment of the complexes of the respiratory chain during iron/ascorbate induced peroxidation in rat liver mitochondria. Biochem. Biophys. Acta. 1239:1995;45-50.
25. Roder H.M., Ingram V.M. Two novel kinases phosphorylate tau and the KSP site of heavy neurofilament subunits in high stoichiometric ratios. J. Neurosci. 11:1991;3325-3343.
26. Sedmak J.J., Grossberg S.E. A rapid, sensitive, and versatile assay for protein using Coomassie brilliant blue G250. Anal. Biochem. 79:1977;544-552.
27. Sheehan J.P., Swerdlow R.H., Parker W.D., Miller S.W., Davis R.E., Tuttle J.B. Altered calcium homeostasis in cells transformed by mitochondria from individuals with Parkinson's disease. J. Neurochem. 68(3):1997;1221-1233.
28. Shigenaga M.K., Hagen T.M., Ames B.N. Oxidative damage and mitochondrial decay in aging. Proc. Natl. Acad. Sci. U.S.A. 91:1994;10771-10778.
29. Shinitzky M., Barenholz Y. Fluidity parameters of lipid regions determined by fluorescence polarization. Biochim. Biophys. Acta. 515:1978;367-394.
30. Stocchi V., Cucchiarini L., Chiarantini L., Palma P., Crescentini G. Simultaneous extraction and reverse-phase high-performance liquid chromatographic determination of adenine and pyridine nucleotides in human red blood cells. Anal. Biochem. 146:1985;118-124.
31. Swerdlow R.H., Parks J.K., Cassarino D.S., Maguire D.J., Maguire R.S., Bennett J.P. Jr. Cybrids in Alzheimer's disease: a cellular model of the disease? Neurology. 49:1997;918-925.
32. Tappel A.L. Lipid peroxidation damage to cell components. Fed. Proc. 32:1973;1870-1874.
33. Van Zuylen A.J., Bosman G.J., Ruitenbeek W., Van Kalmthout P.J., De Grip W.J. No evidence for reduced thrombocyte cytochrome oxidase activity in Alzheimer's disease. Neurology. 42:1992;1246-1247.
34. Van Blitterswijk W.J., Van Hoeven R.P., Van der Meer B.W. Lipid structural order parameters (reciprocal of fluidity) in biomembranes derived from steady-state fluorescence polarization measurements. Biochim. Biophys. Acta. 644:1981;323-332.
35. Vatassery G.T., Maynard U.R., Hagen D.F. High performance liquid chromatography of various tocopherols. J. Chromatogr. 161:1978;299-302.
36. Viani P., Cervato G., Fionilli A., Cestaro B. Age-related differences in synaptosomal peroxidative damage and membrane properties. J. Neurochem. 56:1991;253-258.
37. Wharton D.C., Tzagotoff A. Cytochrome oxidase from beef heart mitochondria. Methods Enzymol. 10:1967;245-250.